Development of nephrotic syndrome after administration of sorafenib in a case of metastatic renal cell carcinoma - Abstract

Department of Urology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.

 

Nephrotic syndrome, after administration of tyrosine kinase inhibitors, is uncommon and not well known. A 62-year-old male, who had experienced a left nephrectomy due to a traffic accident 38 years ago, underwent a partial nephrectomy for right renal cell carcinoma (RCC). Histologically, the tumor was a clear cell RCC. Two years later abdominal CT revealed para-aortic lymph node metastasis. During these two years, serum creatinine had increased from 2.0 mg/dL to 2.9 mg/dL along with the appearance of proteinuria. After only a week of sorafenib, 400 mg/day, fever developed and sorafenib was stopped. Although normotensive, his serum creatinine increased to 3.83 mg/dL and serum albumin decreased from 1.8 g/L to 1.0 g/L. Proteinuria also worsened to 27.5 g/day. He became edematous, and ascites and cardiac effusions also appeared. He was diagnosed with nephrotic syndrome. A retrospective review of the histology of the partial nephrectomy revealed no change in the glomeruli.

Written by:
Okuno Y, Kume H, Hosoda C, Homma Y.   Are you the author?

Reference: Case Report Med. 2011;2011:710216.
doi: 10.1155/2011/710216

PubMed Abstract
PMID: 22007236

UroToday.com Renal Cancer Section